Inovio Pharmaceuticals, Inc.INONASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-104.56M
↑ 11% above average
Average (9y)
$-117.26M
Historical baseline
Range
High:$-15.22M
Low:$-217.18M
CAGR
+23.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-104.56M | +16.1% |
| 2023 | $-124.69M | +42.6% |
| 2022 | $-217.18M | -0.1% |
| 2021 | $-216.94M | -20.9% |
| 2020 | $-179.50M | -81.6% |
| 2019 | $-98.84M | -30.7% |
| 2018 | $-75.64M | -2.9% |
| 2017 | $-73.50M | -10.5% |
| 2016 | $-66.49M | -336.9% |
| 2015 | $-15.22M | - |